Home
Conditions
Refractory Solid Tumors

Clinical trial condition

Refractory Solid Tumors

Explore clinical trials studying Refractory Solid Tumors. Study availability and eligibility vary by location and protocol.

26 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Refractory Solid Tumors trial results

Completed

A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc Interval

NCT01525394

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Charles River Tacoma, Washington, United States

View Trial Details

Completed

Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors

NCT02691793

Conditions: Refractory Solid Tumors
Locations: Samsung Medical Center Seoul, Seoul, Korea, Republic of, South Korea

View Trial Details

Completed

Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors

NCT02688881

Conditions: Refractory Solid Tumors
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

Study to Evaluate the Safety and Efficacy of Pazopanib, in Subject With Refractory Solid Tumors

NCT02691767

Conditions: Refractory Solid Tumors
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

Single-arm Study to Evaluate the Safety and Efficacy of Sunitinib, in Subjects With RET Fusion Positive or FGFR2 Amplification, Refractory Solid Tumors

NCT02450123

Conditions: Refractory Solid Tumors
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

Single-arm Study to Evaluate the Safety and Efficacy of Pazopanib, in Subjects With FGFR2 Amplification, FGFR2 Mutation Refractory Solid Tumors

NCT02450136

Conditions: Refractory Solid Tumors
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors

NCT02596503

Conditions: Refractory Solid Tumors, Relapsed Solid Tumors
Locations: Children's Hospital Colorado Aurora, Colorado, United States

University of Kentucky Lexington, Kentucky, United States

University of Texas, Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Completed

A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10

NCT02482441

Conditions: Advanced Relapsed Tumors, Colonic Diseases, Colorectal Neoplasms, +10 more
Locations: UCSF San Francisco, California, United States

University of Colorado Hospital Anschulz Cancer Pavilion Aurora, Colorado, United States

Yale New Haven, Connecticut, United States

Massachusetts General Hospital, Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors

NCT03052205

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Scottsdale Healthcare Hospitals DBA Honor Health Scottsdale, Arizona, United States

The University of Arizona Cancer Center Tucson, Arizona, United States

University of California San Francisco (UCSF) San Francisco, California, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Single-arm Study to Evaluate the Safety and Efficacy of Sorafenib, in Subjects With BRAF Mutation Refractory Solid Tumors

NCT02450149

Conditions: Refractory Solid Tumors
Locations: Samsung Medical Center Seoul, Seoul, Korea, Republic of, South Korea

View Trial Details

Refractory Solid Tumors

Refractory Solid Tumors trial results

Related conditions